News Releases

2021.03.29
Adagene Announces Clinical Advancement for ADG116
-NEObody™ product candidate ADG116 has been well tolerated in ongoing Phase 1 clinical trial-  -Promising pharmacodynamic biomarker signals demonstrate clinical proof of mechanism- -Poised for global expansion- SAN FRANCISCO and SUZHOU, China, March 29, 2021 (GLOBE NEWSWIRE) -- Adagene Inc. ... read more »
Displaying 16 - 20 of 28